Physiological Role
Gamma-glutamyltransferase is a membrane-bound enzyme present on the surface of cells in several organs, primarily the liver, kidneys and pancreas. Its central role involves cleaving the gamma-glutamyl bond of extracellular glutathione, the body’s primary antioxidant system. This cleavage releases glutathione’s constituent amino acids (cysteine, glutamate, glycine), enabling their reabsorption and intracellular glutathione resynthesis.
Unlike ALT, an intracellular enzyme released upon hepatocyte damage, GGT is anchored in the cell membrane. It actively participates in the glutathione cycle, called the gamma-glutamyl cycle. This membrane position is associated with its sensitivity to numerous metabolic, toxic and inflammatory factors. Hepatic stress, even moderate, can stimulate GGT synthesis.
In blood, circulating GGT primarily originates from the liver, although the enzyme is expressed in other tissues. This is why a serum elevation is interpreted as a hepatic signal, even though extra-hepatic factors can also influence it.
Reference Ranges
Depending on the biomarker, Singular ranges are based on a synthesis of nutritional or clinical reference points and longevity research. They do not replace your laboratory's reference values or your healthcare professional's advice.
Biological Significance
A GGT level in the optimal range corresponds to low enzyme activity at the time of sampling. This scenario is associated with a favorable metabolic profile in long-term follow-up studies.
Elevated values constitute a metabolic warning signal. Alcohol is its main factor of elevation. Its elevation can also accompany fat accumulation in the liver, a disrupted metabolic profile or slowed bile flow. Recent research shows that elevated GGT, even in isolation, is an independent predictor of cardiovascular risk.
Very low values are generally reassuring and reflect low hepatic stress. Unlike ALT, a very low GGT level is not associated with specific risks in current literature.
GGT reading gains full meaning when combined with ALT. A joint elevation of both markers suggests more global hepatocellular stress than an elevation of GGT alone. The trend of values over time is more informative than a single measurement.
Influencing Factors
Alcohol. Alcohol is the main factor that raises GGT. Even regular moderate intake can elevate values. After cessation, GGT declines gradually, over several weeks.
Medications. Antiepileptics (phenytoin, carbamazepine), certain antibiotics and non-steroidal anti-inflammatory drugs can induce GGT elevation. Oral contraceptives and hormone replacement raise levels by about 10% on average.
Body composition. Obesity and visceral adiposity are factors of chronic GGT elevation. A disrupted metabolic profile is strongly correlated with elevated values, independently of alcohol consumption.
Diet. A caloric excess rich in saturated fats and refined sugars promotes fat accumulation in the liver and GGT elevation. Conversely, a diet rich in fruits, vegetables and coffee is associated with lower values in epidemiological studies.
Age and sex. Men present higher GGT values than women. Levels increase with age in both sexes, making longitudinal monitoring particularly relevant.
Tobacco. Smoking is an independent factor of GGT elevation, likely related to increased oxidative burden on the liver.
Physical activity. Regular physical activity is associated with lower GGT values. This effect is particularly marked in overweight individuals or those with a disrupted metabolic profile.
In the Singular Formula
GGT is among the liver markers Singular integrates into the biological profile. No formulation engine rule adjusts a dosage in response to this marker.
When GGT is in the high or very high range, the formulation engine activates a rule dedicated to liver function. This rule adjusts no dosage: it delivers dietary guidance content. ALT triggers the same rule independently. A second guidance rule combines elevated GGT with elevated triglycerides.
Measuring GGT and ALT together widens coverage: either one is enough to activate the hepatic guidance. The cross-reading with triglycerides then separates isolated hepatic stress from a broader metabolic profile.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Ruttmann E. et al. | 2005 | Cohort Study | Circulation | View on PubMed |
Gamma-glutamyltransferase as a risk factor for cardiovascular disease mortality: an epidemiological investigation in a cohort of 163,944 Austrian adults In this Austrian cohort of 163,944 adults followed for up to 17 years, elevated GGT is significantly associated with cardiovascular mortality in both men and women, with a dose-response relationship. | ||||
| Fraser A. et al. | 2007 | Meta-analysis | Arteriosclerosis, Thrombosis, and Vascular Biology | View on PubMed |
Gamma-glutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British Women's Heart and Health Study and Meta-Analysis Meta-analysis of ten prospective studies, combined with a cohort of 2,961 British women. GGT is associated with vascular events independently of alcohol intake. The article was the subject of an erratum. | ||||
| Du G. et al. | 2013 | Meta-analysis | Preventive Medicine | View on PubMed |
Gamma-glutamyltransferase is associated with cardiovascular and all-cause mortality: a meta-analysis of prospective cohort studies Meta-analysis of seven prospective studies involving 273,141 participants. Elevated GGT is an independent predictor of cardiovascular and all-cause mortality. | ||||
| Kunutsor S.K. et al. | 2014 | Meta-analysis | International Journal of Epidemiology | View on PubMed |
Liver enzymes and risk of all-cause mortality in general populations: a systematic review and meta-analysis Systematic review of 19 cohorts and more than 9.2 million participants. It evaluates the link between liver enzymes (GGT, ALT, AST, ALP) and all-cause mortality in general populations. GGT and ALP are associated with mortality risk. | ||||
| Koenig G. et Seneff S. | 2015 | Review | Disease Markers | View on PubMed |
Gamma-Glutamyltransferase: A Predictive Biomarker of Cellular Antioxidant Inadequacy and Disease Risk Review proposing that GGT be read as an indicator of cellular antioxidant status. Under this hypothesis, elevated GGT would reflect increased glutathione demand. This reading remains a proposal by the authors. | ||||
| Whitfield J.B. | 2001 | Review | Critical Reviews in Clinical Laboratory Sciences | View on PubMed |
Gamma glutamyl transferase Reference review on GGT biochemistry, physiology and clinical significance. Describes enzymatic regulation mechanisms and causes of serum elevation. | ||||
| Lee D.H. et al. | 2004 | Review | Free Radical Research | View on PubMed |
Is serum gamma glutamyltransferase a marker of oxidative stress? Review exploring the relationship between serum GGT and oxidative stress markers. The authors propose GGT as an indirect indicator of systemic oxidative stress. | ||||